Susceptibility to in vitro lipid peroxidation of low density lipoproteins and erythrocyte membranes from liver cirrhotic patients

References

• Parthasarathy S, Khoo J C., Miller E, Barnett J, Witztum J C., Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 1990; 87: 3894–8
   PubMed Web of Science ®Google Scholar
• Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-tocopherol on the vitamin E content of human low density lipoproteins and resistence to oxidation. J Lipid Res 1991; 32: 1325–32
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jurgens G. Biochemical, structural and functional properties of oxidized low density lipoprotein. Chem Res Toxical 1990; 3: 77–92
   PubMed Web of Science ®Google Scholar
• Panasenko O M., Vol'nova T V., Azizova O A., Vladimorov Y A. Free radical modification of lipoproteins and cholesterol accumulation in cells upon atherosclerosis. Free Rad Biol. Med. 1991; 10: 137–48
   Google Scholar
• Steinberg D, Parthasarathy S, Carew T E., Khoo J C., Witztum J C. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–24
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Jurgens D, Quehenberger O, Koller E. Autooxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 1987; 28: 495–509
   PubMed Web of Science ®Google Scholar
• Alcindor L G., Antebi H. Determination of LDL susceptibility to oxidation. Molecular biology of atherosclerosis, M J. Halpern. John Libbey & Company Ltd, 383–388
   Google Scholar
• Arshad M AQ, Bhadra S, Cohen R M., Subbiah M TR. Plasma lipoprotein peroxidation potential: a test to evaluate individual susceptibility to peroxidation. Clin. Chem. 1991; 37: 1756–8
   PubMed Web of Science ®Google Scholar
• Lavy A, Brook G J., Dankner G, Amotz A B., Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991; 40: 794–9
   PubMed Web of Science ®Google Scholar
• Duhamel G, Nalpas B, Goldstein S, Laplaud P M., Berthelot P, Chapman M J. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury. Hepatology 1984; 4: 577–85
   PubMedGoogle Scholar
• Patek A J., Earampamoorthy S. Serum lipids in alcolholic patients with and without cirrhosis of the liver with a particular reference to endogenous familial hypertriglyceridemia. Am J Clin Nutr 1976; 29: 1122–6
   Google Scholar
• Fonda M, Cattin L, Da Col P G., Dieplinger H, Tiribelli C. Serum apoprotein Al, Apoprotein A2 levels and lecithin-cholesterol acyltransferase activity in compensated cirrhosis. Ital J Gastroenterol 1985; 17: 258–61
   Google Scholar
• Kanel G C., Radvan G, Peters R L. High-density lipoprotein cholesterol and liver disease. Hepatology 1983; 3: 343–8
   PubMed Web of Science ®Google Scholar
• Rossner S, Johansson C, Walldius G, Aly A. Intra-lipid clearance and lipoprotein pattern in men with advanced alcoholic liver cirrhosis. Am J Clin Nutr 1979; 32: 2022–6
   PubMed Web of Science ®Google Scholar
• Caren R, Corbo L. Plasma fatty acids in pancreatic cystic fibrosis and liver disease. J Clin Endocrinol. 1966; 26: 470–7
   Google Scholar
• Gunnlaugsson O, Berkowitz D. Individual free fatty acids in patients with liver disease. Am J Dig Dis 1977; 22: 1005–9
   Google Scholar
• Salvioli G, Lugli R, Gaetti E. Lipoprotein and erythrocyte modifications induced by polyunsaturated lecithin infusion. Molecular aspects of human disease, J W. Gorrod, O Albano, S. Papa. Vol l: 115–120
   Google Scholar
• Abat A, Cabre E, Gonzalez-Huix F, et al. Influence of the nutritional status in the prognosis and clinical outcome of hospitalized patients with liver cirrhosis. Preliminary report. J Clin Nutr Gastroenterol 1987; 2: 63–8
   Google Scholar
• Sugiura M, Oikawa T, Hirano K, et al. A simple colorimetric method for determination of serum triglycerides with protein lipase and glycerol dehydrogenase. Clin Chim Acta 1977; 81: 125–30
   PubMed Web of Science ®Google Scholar
• Allain C C., Poon L S., Chan C SG, Richmond W, Fu P C. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470–5
   PubMed Web of Science ®Google Scholar
• Takayama M, Itoh S, Nagasaki T, Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 1977; 79: 93–8
   PubMed Web of Science ®Google Scholar
• Goudard M, Aubry C, Alcindor L G. Etude ďun reactif precipitant selectivament les LDL: Verne colloque international de biologie prospective. Ann Biol Clin 1982; 40: 466
   Google Scholar
• Burton G W., Ingold K U., Thompson K E. An improved procedure for the isolation of ghost membranes from human red blood cells. Lipids 1981; 16: 946
   PubMed Web of Science ®Google Scholar
• Zak B. Simple rapid microtechnic for serum total cholesterol. Am J Clin Path 1957; 27: 583–8
   PubMed Web of Science ®Google Scholar
• Bartlett G R. Phosphorus assay in column chromatography. J Biol Chem 1959; 234: 466–8
   PubMed Web of Science ®Google Scholar
• Halliwell B. Hydrazine. Free radicals in biology and medicine,2nd edn, B Halliwell, J MC Gutteridge. Clarendon press, Oxford 1989; 324–6
   Google Scholar
• Gilbert H S., Roth E F., Ginsberg H. Increased erythrocyte susceptibility to lipid peroxidation in myeloproliferative disorders. J Lab Clin Med 1984; 103: 6–12
   PubMedGoogle Scholar